Showing results (81-90 of 242) with videos related to
Sort By:
Pageof 25
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 20, 2016
Primary Double-Strike Therapy for Cancers to Overcome EGFR Kinase Inhibitor Resistance: Proposal from the BenchKenichi Suda, Paul A Bunn, Christopher J Rivard, et al.Drug Design, Development and Therapy|May 8, 2018
The combination of anti-KIR monoclonal antibodies with anti-PD-1/PD-L1 monoclonal antibodies could be a critical breakthrough in overcoming tumor immune escape in NSCLCYayi He, Sangtian Liu, Jane Mattei, et al.The American Journal of Pathology|July 5, 2011
Standardization of epidermal growth factor receptor (EGFR) measurement by quantitative immunofluorescence and impact on antibody-based mutation detection in non-small cell lung cancerAnastasios Dimou, Seema Agarwal, Valsamo Anagnostou, et al.Future Oncology (London, England)|April 19, 2021
Real-world characteristics and outcomes of advanced non-small-cell lung cancer patients with <i>EGFR</i> exon 19 deletions or exon 21 mutationsKatherine B Winfree, Cliff Molife, Patrick M Peterson, et al.Lung Cancer (Amsterdam, Netherlands)|January 23, 2010
New strategies to overcome limitations of reversible EGFR tyrosine kinase inhibitor therapy in non-small cell lung cancerRobert C Doebele, Ana B Oton, Nir Peled, et al.Seminars in Oncology|March 15, 2002
Epidermal growth factor receptor family in lung cancer and premalignancyWilbur A Franklin, Robert Veve, Fred R Hirsch, et al.Seminars in Oncology|March 15, 2002
HER2/neu expression in malignant lung tumorsFred R Hirsch, Wilbur A Franklin, Robert Veve, et al.Nanomedicine : Nanotechnology, Biology, and Medicine|October 29, 2011
Classification of lung cancer histology by gold nanoparticle sensorsOrna Barash, Nir Peled, Ulrike Tisch, et al.Journal of Pediatric Hematology/Oncology|June 22, 2021
Rapid Response to Lorlatinib in a Patient With TFG-ROS1 Fusion Positive Inflammatory Myofibroblastic Tumor of the Chest Wall Metastatic to the Brain and Refractory to First and Second Generation ROS1 InhibitorsBenjamin Carcamo, Ranjan Bista, Harry Wilson, et al.Urologia Internationalis|July 23, 2008
Efficacy of doxazosin in the treatment of acute urinary retention due to benign prostate hyperplasiaLuis Prieto, Jesús Romero, Cristóbal López, et al.Pageof 25